{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:03:09Z","timestamp":1792735389281,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.neurol.2022.03.009","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T08:09:37Z","timestamp":1652861377000},"page":"422-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["When does Huntington disease begin?"],"prefix":"10.1016","volume":"178","author":[{"given":"A.","family":"Durr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neurol.2022.03.009_bib0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2016.2215","article-title":"Expanding the spectrum of genes involved in huntington disease using a combined clinical and genetic approach","volume":"73","author":"Mariani","year":"2016","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2022.03.009_bib0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"Lee","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2022.03.009_bib0100","first-page":"887e14","article-title":"CAG repeat not polyglutamine length determines timing of Huntington's disease onset","volume":"178","author":"Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium","year":"2019","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.neurol.2022.03.009_bib0105","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1474-4422(20)30343-4","article-title":"Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies","volume":"19","author":"Wright","year":"2020","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2022.03.009_bib0110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington's disease","volume":"162","author":"Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neurol.2022.03.009_bib0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ana.24656","article-title":"DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases","volume":"79","author":"Bettencourt","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.03.009_bib0120","doi-asserted-by":"crossref","first-page":"e64674","DOI":"10.7554\/eLife.64674","article-title":"Propensity for somatic expansion increases over the course of life in Huntington disease","volume":"10","author":"Kacher","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.neurol.2022.03.009_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(14)70238-8","article-title":"Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study","author":"Paulsen","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.03.009_bib0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jmg.31.7.555","article-title":"Guidelines for the molecular genetics predictive test in Huntington's disease","volume":"31","author":"International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea","year":"1994","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2022.03.009_bib0135","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ejhg.2016.36","article-title":"22 years of predictive testing for Huntington's disease: the experience of the UK Huntington's prediction consortium","volume":"24","author":"UK Huntington's Disease Prediction Consortium","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2022.03.009_bib0140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neurol.2015.02.016","article-title":"Guidelines for presymptomatic testing for Huntington's disease: past, present and future in France","volume":"171","author":"Cl\u00e9ment","year":"2015","journal-title":"Rev Neurol (Paris)"},{"issue":"8","key":"10.1016\/j.neurol.2022.03.009_bib0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jmedgenet-2016-104199","article-title":"A liminal stage after predictive testing for Huntington disease","volume":"54","author":"Gargiulo","year":"2017","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.neurol.2022.03.009_bib0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early-stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2022.03.009_bib0155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1474-4422(20)30143-5","article-title":"Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis","volume":"19","author":"Scahill","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.03.009_bib0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","article-title":"YKL40 in the brain and cerebrospinal fluid of neurodegenerative dementias","volume":"12","author":"Llorens","year":"2017","journal-title":"Mol Neurodegener"},{"issue":"6505","key":"10.1016\/j.neurol.2022.03.009_bib0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.aax3338","article-title":"Huntington's disease alters human neurodevelopment","volume":"369","author":"Barnat","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neurol.2022.03.009_bib0170","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntington expression in patients with Huntington's disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"NEJM"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722005707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722005707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:44:30Z","timestamp":1758519870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378722005707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0035378722005707"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.03.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When does Huntington disease begin?","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}